Concepedia

Birgit Wackwitz

BW

6

Publications

425

Citations

6

H-Index

2006

Active since

Affiliations

Novartis (Germany)(Current)

University of Tübingen

Heinrich Heine University Düsseldorf

Kantonsspital St. Gallen

Saarland University

Birgit Wackwitz is an author at Novartis (Germany) specializing in breast cancer, oncology, and cancer therapeutics.

Top concepts

Publications per year

2006–2014

6

Publications

6

Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells

Oliver Treeck, Birgit Wackwitz, Ulrike Haus et al. · Gynecologic Oncology · 2006 · 96 citations

, , +10

Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: A phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy

U. Krainick‐Strobel, W. Lichtenegger, D. Wallwiener et al. · BMC Cancer · 2008 · 87 citations · Full text

Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients

EF Solomayer, Gerhard Gebauer, P. Hirnle et al. · Annals of Oncology · 2012 · 83 citations · Full text

, , +8

Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial

Małgorzata Banyś, Erich‐Franz Solomayer, Gerhard Gebauer et al. · BMC Cancer · 2013 · 75 citations · Full text

Influence of zoledronic acid on disseminated tumor cells (DTC) in primary breast cancer patients.

Erich‐Franz Solomayer, Gerhard Gebauer, P. Hirnle et al. · Cancer Research · 2009 · 59 citations

, , +18

Rows per page

1–5 of 6